Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
Tempus claims AI pathology developer Paige in $81M deal
Tempus bought the former Fierce 15 winner in part for its spanning nearly 7 million digitized pathology slides and clinical data from MSKCC.
Conor Hale
Aug 22, 2025 12:30pm
Kite sails into in vivo CAR-T space via $350M Interius buyout
Aug 21, 2025 9:59am
Painted into a corner, Mural agrees to Xoma buyout
Aug 20, 2025 10:28am
Private equity firm acquires site network Headlands Research
Aug 18, 2025 1:53pm
10x Genomics scoops up Scale Bio for single-cell analysis
Aug 8, 2025 12:22pm
FTC aims to stop Edwards' acquisition of JenaValve
Aug 7, 2025 11:33am
